While cannabinoids offer a potential alternative for refractory chronic pain, optimal use requires personalized dosing and ...

Düsseldorf, Germany Wednesday, February 5, 2025, 18:00 Hrs [IST] ...

Allosteric GABAA-receptor modulator AP-325 showed rapid onset as well as long-lasting pain reduction in patients with chronic neuropathic pain in Phase 2a study Data confirm previously reported ...

Algiax Pharmaceuticals, a clinical-stage biotech company focused on developing innovative treatments for chronic neuropathic pain, today announced compelling topline data from its Phase 2a clinical ...

It is important to add pain management to leprosy treatment protocols. This can reduce the challenges that patients face. Read on.

After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...

The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.

Richard Rosenquist, enterprise chairman in the department of pain management in the Neurological Institute at the Cleveland ...

The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...

Under this condition, which can result from traumatic injuries, infections, metabolic problems, or could be inherited due to ...

Chronic pain is a global health challenge, with current treatment options often limited by side effects, addiction risk, and diminished effectiveness over time. In a new study, Yale researchers ...